Demo QCI Interpret at AMP 2018 to explore evidence-based reporting for any cancer, any assay, on your platform!
As the journey to precision medicine transitions from a pure research endeavor to a means of providing clinically-relevant information for disease, interpreting the data from next-generation sequencing (NGS)-based clinical assays presents an ongoing challenge. Whether cost, complexity or capacity, today’s clinical labs face significant roadblocks.
That’s why we developed QCI Interpret. Software designed to classify and interpret pathogenic variants in any disease, QCI Interpret coalesces available data across more than one million patient samples and 16 million biological findings to build the broadest evidence base for annotating variants. With QCI Interpret, you get simple reports that clearly direct oncologists to the cancer gene-based vulnerabilities of each patient’s tumor, indicated therapies, clinical trials, and other actionable information, such as poor or good prognosis alterations–all accompanied by clickable hyperlinks supporting these assertions.
Learn how clinical decision support tools, such as QCI Interpret, can streamline workflows, standardize evidence-based practices, and improve patient outcomes!